BRPI0913592A2 - formas polimórficas do ácido (4- {[(5- {[(3-clorofenil) metil] oxi}- 2-metilfenil) carbonil] amino}- 3-metilfenil) acético - Google Patents

formas polimórficas do ácido (4- {[(5- {[(3-clorofenil) metil] oxi}- 2-metilfenil) carbonil] amino}- 3-metilfenil) acético

Info

Publication number
BRPI0913592A2
BRPI0913592A2 BRPI0913592A BRPI0913592A BRPI0913592A2 BR PI0913592 A2 BRPI0913592 A2 BR PI0913592A2 BR PI0913592 A BRPI0913592 A BR PI0913592A BR PI0913592 A BRPI0913592 A BR PI0913592A BR PI0913592 A2 BRPI0913592 A2 BR PI0913592A2
Authority
BR
Brazil
Prior art keywords
methylphenyl
chlorophenyl
oxy
carbonyl
amino
Prior art date
Application number
BRPI0913592A
Other languages
English (en)
Inventor
Sarah Vallance
Original Assignee
Glaxo Group Limided
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limided filed Critical Glaxo Group Limided
Publication of BRPI0913592A2 publication Critical patent/BRPI0913592A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0913592A 2008-06-10 2009-06-08 formas polimórficas do ácido (4- {[(5- {[(3-clorofenil) metil] oxi}- 2-metilfenil) carbonil] amino}- 3-metilfenil) acético BRPI0913592A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0810617.1A GB0810617D0 (en) 2008-06-10 2008-06-10 Novel pharmaceutical
PCT/EP2009/057008 WO2009150119A1 (en) 2008-06-10 2009-06-08 Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid

Publications (1)

Publication Number Publication Date
BRPI0913592A2 true BRPI0913592A2 (pt) 2015-11-24

Family

ID=39650769

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913592A BRPI0913592A2 (pt) 2008-06-10 2009-06-08 formas polimórficas do ácido (4- {[(5- {[(3-clorofenil) metil] oxi}- 2-metilfenil) carbonil] amino}- 3-metilfenil) acético

Country Status (14)

Country Link
US (1) US20110086921A1 (pt)
EP (1) EP2303832A1 (pt)
JP (1) JP2011522857A (pt)
KR (2) KR20110027686A (pt)
CN (1) CN102119141A (pt)
AU (1) AU2009256689A1 (pt)
BR (1) BRPI0913592A2 (pt)
CA (1) CA2727594A1 (pt)
EA (1) EA201071410A1 (pt)
GB (1) GB0810617D0 (pt)
IL (1) IL209430A0 (pt)
MX (1) MX2010013524A (pt)
WO (1) WO2009150119A1 (pt)
ZA (1) ZA201008123B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2488020B1 (en) * 2009-10-13 2016-12-14 Wellstat Therapeutics Corporation 3-substituted compounds for reducing uric acid
KR101695071B1 (ko) 2014-12-26 2017-01-11 연세대학교 산학협력단 액상으로 약물을 분산시킨 필름형태의 약제학적 조성물
US10407376B2 (en) 2015-01-16 2019-09-10 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method to prepare phenolics from biomass
EP3184505A1 (en) 2015-12-22 2017-06-28 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Method for preparing phenolics using a catalyst

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000068203A1 (en) * 1999-05-07 2000-11-16 Takeda Chemical Industries, Ltd. Cyclic compounds and uses thereof
WO2008071736A1 (en) * 2006-12-15 2008-06-19 Glaxo Group Limited Benzamide derivatives as ep4 receptor agonists

Also Published As

Publication number Publication date
ZA201008123B (en) 2011-10-26
KR20110027686A (ko) 2011-03-16
IL209430A0 (en) 2011-01-31
US20110086921A1 (en) 2011-04-14
WO2009150119A1 (en) 2009-12-17
MX2010013524A (es) 2010-12-21
AU2009256689A1 (en) 2009-12-17
EA201071410A1 (ru) 2011-06-30
EP2303832A1 (en) 2011-04-06
KR20110027685A (ko) 2011-03-16
JP2011522857A (ja) 2011-08-04
CA2727594A1 (en) 2009-12-17
GB0810617D0 (en) 2008-07-16
CN102119141A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
BRPI0914959A2 (pt) sais recentes de ácido (4{[(5-{[(3-clorofenil)metil]oxi}-2-metilfenil)carbonila]amino}-3-metilfenil)acético
BRPI0919090A2 (pt) prepraração de ácido acético.
EP2005957A4 (en) ACID SECRETION INHIBITOR
IL208004A (en) Compounds for reducing uric acid and uses thereof
DK2361256T3 (da) Cyclohexenyl-nukleinsyreanaloger
EP2281080A4 (en) POLYLACTIC ACID FIBERS
EP3450425C0 (en) PERCARBOXYLIC ACID COMPOSITION
DE602007004372D1 (de) Hochfrequenzmodul
EP2037433A4 (en) DISPLAY AND METHOD FOR PRODUCING THE SAME
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
BRPI0715617A2 (pt) Derivados do ácido fenoxifenilacético 4-substituído
BRPI0918602A2 (pt) composto (i)
EP2307422A4 (en) NEW SPIROCHROMANONE CARBOXYLIC ACIDS
BRPI0911849A2 (pt) protetores solares
DE602006013513D1 (de) Enzymatische herstellung von persäuren aus carbonsäureestersubstraten mittels nicht-häm-haloperoxidasen
EP2275414A4 (en) Cyclopentylacrylic acid amide derivative
BRPI0921038A2 (pt) ácido naftilacéticos
BRPI0918533A2 (pt) Composição pesticida compreendendo um derivado de ácido alfa-alcoxifenil acético e um composto neonicotinoide
DK1986928T3 (da) Palle
DE602007011911D1 (de) Stark hydrophober verbundstoff
BRPI0913592A2 (pt) formas polimórficas do ácido (4- {[(5- {[(3-clorofenil) metil] oxi}- 2-metilfenil) carbonil] amino}- 3-metilfenil) acético
EP2323229A4 (en) pole
BRPI0918146A2 (pt) corantes ácidos
DE602007010931D1 (de) Säurefarbstoffe
DK1996027T3 (da) Harpiksindkapslet næringsmiddelsyre

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]